Zobrazeno 1 - 10
of 286
pro vyhledávání: '"M. V. Shestakova"'
Autor:
N. V. Rusyaeva, I. V. Kononenko, O. K. Vikulova, M. A. Isakov, M. V. Shestakova, N. G. Mokrysheva
Publikováno v:
Сахарный диабет, Vol 27, Iss 4, Pp 321-335 (2024)
BACKGROUND: Molecular genetic testing (MGT) is increasingly accessible, improving diagnosis of monogenic diabetes (DM), particularly maturity-onset diabetes of the young (MODY). While most MODY research focuses on pediatric populations, diagnosis is
Externí odkaz:
https://doaj.org/article/d90fb4c7825c4c739a8a235ebe00e667
Autor:
M. V. Shestakova, E. V. Biryukova
Publikováno v:
Сахарный диабет, Vol 27, Iss 4, Pp 347-356 (2024)
BACKGROUND: To date, the results of Metformin, Gosogliptin and combination thereof have not been studied on a large patient population with type 2 diabetes mellitus (DM2), including comorbid patients, in real clinical settings in the Russian Federati
Externí odkaz:
https://doaj.org/article/5254a4d6fe564d3ca93f1682595ab416
Autor:
N. G. Mokrysheva, M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, I. G. Bakulin, T. V. Vavilova, G. R. Galstyan, T. Y. Demidova, F. K. Dzgoeva, T. L. Karonova, E. А. Lukina, A. M. Mkrtumyan, N. А. Petunina, R. V. Ponomaryov, N. A. Suponeva, O. Y. Sukhareva, M. S. Shamkhalova
Publikováno v:
Сахарный диабет, Vol 27, Iss 4, Pp 402-404 (2024)
An erratum on « Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice» by Natalya G. Mokrysheva, Marina V. Shestakova, Alexander S. Ametov, Mikhail B. Antsiferov, Igor G. Bakulin, Tatiana V. Vavilova, Gagik R. Galstya
Externí odkaz:
https://doaj.org/article/f3a3e60a6bf642f988972646d18271a9
Autor:
M. V. Shestakova, G. A. Melnichenko, E. N. Andreeva, O. Y. Sukhareva, S. Y. Vorotnikova, L. I. Ibragimova, F. F. Burumkulova, T. Y. Demidova, E. G. Deryabina, A. V. Tiselko, V. S. Chulkov
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 302-313 (2024)
Due to its effect on insulin resistance, ease of administration and favorable safety profile, metformin has been included in the recommendations of foreign medical communities for the management of pregnant women with hyperglycemia since 2008. Howeve
Externí odkaz:
https://doaj.org/article/209c1f4c5a66414fbcd85805415b8061
Autor:
N. G. Mokrysheva, M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, I. G. Bakulin, T. V. Vavilova, G. R. Galstyan, T. Y. Demidova, F. K. Dzgoeva, T. L. Karonova, E. A. Lukina, A. M. Mkrtumyan, N. A. Petunina, R. V. Ponomaryov, N. A. Suponeva, O. Y. Sukhareva, M. S. Shamkhalova
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 314-320 (2024)
On March 20, 2024, an interdisciplinary meeting of the Expert Council on the current problem of B12 insufficiency/deficiency and the prevalence of this condition among endocrine patients was held at the Endocrinology Research Centre (Moscow). The pur
Externí odkaz:
https://doaj.org/article/8829d05cc33f43caab1c815842313903
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 287-294 (2024)
Lipodystrophy syndromes are a heterogeneous group of extremely rare, inherited or acquired disorders that are characterized by total or partial fat loss or its improper redistribution. The prevalence of lipodystrophies is estimated to be 1:1,000,000
Externí odkaz:
https://doaj.org/article/a3442905e229431e924cffe49492a49f
Autor:
R. V. Rozhivanov, M. O. Chernova, V. A. Ioutsi, G. A. Mel’nichenko, M. V. Shestakova, E. R. Rozhivanova, E. N. Andreeva, N. G. Mokrysheva
Publikováno v:
Сахарный диабет, Vol 27, Iss 2, Pp 120-129 (2024)
BACKGROUND: It is important to evaluate the effect of androgen replacement therapy on glycemic control.AIMS: Assessment of the effect of transdermal testosterone therapy on glycemic control in men with hypogonadism and T2DM.MATERIALS AND METHODS: The
Externí odkaz:
https://doaj.org/article/1533a0b748ad46d8bcfc5ce8ea4f2f95
Autor:
M. V. Shestakova, G. R. Vagapova, O. K. Vikulova, G. R. Galstyan, T. Yu. Demidova, E. N. Dudinskaya, T. P. Kiseleva, A. M. Mkrtumyan, N. A. Petunina, O. N. Tkacheva, V. V. Fadeev, Y. S. Khalimov, E. A. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 619-625 (2023)
TThe annual increase in the prevalence of type 2 diabetes mellitus emphasizes the relevance of the search for new treatment options, along with necessity for regular review of proven therapeutic solutions. Today, dipeptidyl peptidase-4 inhibitors (DP
Externí odkaz:
https://doaj.org/article/a9f62b279e3c4b2aa4fd5e55d9c3b6e3
Autor:
M. I. Yevloyeva, M. S. Arutyunova, A. S. Severina, N. P. Trubitsyna, N. V. Zaitseva, M. S. Shamhalova, M. V. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 504-514 (2023)
BACKGROUND: Patients with type 1 diabetes mellitus (T1D) have an earlier age of onset and a longer course of the disease, already by middle age they have the development of microand macrovascular diabetic complications that reduce the quality and dur
Externí odkaz:
https://doaj.org/article/e51849fd17344503949a819e7f0ffa35
Autor:
M. S. Shamkhalova, O. K. Vikulova, A. V. Zheleznyakova, M. A. Isakov, M. V. Shestakova, I. I. Dedov, N. G. Mokrysheva
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 404-417 (2023)
BACKGROUND: Chronic kidney disease (CKD) in diabetes mellitus (DM) is a supranosological concept that characterizes multifactorial kidney damage associated with increased cardiovascular and mortality risk, which determines the high medical and social
Externí odkaz:
https://doaj.org/article/05e2ef2db7c746a68f0ff626f0523446